According to the World Health Organization, more than 2 million new cases of breast cancer were diagnosed in 2018, a figure equivalent to the number of new cases of lung cancer. Despite significant advances in care, breast cancer remains a leading cause of cancer death among women around the world. Although it occurs less frequently than other subtypes of breast cancer, triple-negative breast cancer (TNBC) is more commonly diagnosed in younger women and associated with increased rates of early recurrence and mortality compared with other subtypes. Additionally, TNBC has historically been considered a difficult cancer to treat, largely due to its aggressive tumor biology and the paucity of available therapies. Heightened understanding of the biology and pathogenesis of TNBC has resulted in new treatment approaches that have the potential to improve outcomes.
How much do you know about TNBC? Test your knowledge with this quick quiz.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Pavani Chalasani. Fast Five Quiz: Triple-Negative Breast Cancer - Medscape - Sep 17, 2020.